Примери за използване на Pharmacokinetic interaction на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
No clinically significant pharmacokinetic interaction.
Prucalopride has a low pharmacokinetic interaction potential.
No pharmacokinetic interaction studies have been completed.
A potential pharmacokinetic interaction with strong inhibitors of UGT1A3
There is no clinically relevant pharmacokinetic interaction of Ketek and theophylline administered as extended release formulation.
No pharmacokinetic interaction was observed between rivastigmine and digoxin, warfarin, diazepam
There is no clinically relevant pharmacokinetic interaction of Levviax and theophylline administered as extended release formulation.
The pharmacokinetic interaction of Pelzont with statins has been studied only with simvastatin(see section 4.4).
In patients with rheumatoid arthritis, no pharmacokinetic interaction between the leflunomide(10 to 20 mg per day)
There is no pharmacokinetic interaction between ropinirole and L-dopa
In the absence of pharmacokinetic interaction studies, alli is not recommended to be used by patients receiving acarbose.
No pharmacokinetic interaction was observed in patients when vinflunine was combined with either cisplatin, carboplatin, capecitabine or gemcitabine.
The pharmacokinetic interaction of Tredaptive with statins has been studied only with simvastatin(see section 4.4).
No clinically significant pharmacokinetic interaction was observed between sirolimus and 0.3 mg norgestrel/ 0.03 mg ethinyl estradiol.
Dexamethasone has no clinically significant pharmacokinetic interaction with thalidomide, lenalidomide,
The pharmacokinetic interaction of Trevaclyn with statins has been studied only with simvastatin(see section 4.4).
In a separate clinical pharmacokinetic interaction study of healthy subjects,
Based on literature data, no clinically relevant pharmacokinetic interaction between paclitaxel and carboplatin is expected.
No pharmacokinetic interaction is expected with medicinal products known to be metabolised by these enzyme systems.
A pharmacokinetic interaction between adefovir and the immunosuppressant, cyclosporin, is also considered unlikely as